Geneious Pro provides tools to process data from sequence chromatograms through to sequence alignment and sequence analysis in a way any molecular biologist will find logical and intuitive
The launch of Geneious Pro in the third quarter of 2006 makes it possible for bioinformatics data sharing to happen easily.
Announcing the release of Geneious Pro, Daniel Batten, CEO of Biomatters, the company that created Geneious, said: "The launch of Geneious Pro is a real answer to the needs of bioinformaticians and scientists when it comes to a bioinformatics application.
"Geneious Pro delivers on many researchers' dream, providing a complete set of tools to process data from sequence chromatograms through to sequence alignment and sequence analysis in a way any molecular biologist will find logical and intuitive, not to mention fast.
"We have also moved to the next key step in the evolution of Geneious with our team providing users with the ability to share information through P2P (peer-to-peer) collaboration".
The P2P function has the ability to access information across a large number of data sources, co-authors and peer-collaborators in a way which is trusted, secure and timely.
Geneious P2P removes the need for central servers or configuration setup, which means installation is automatic, collaboration is flexible and users are mobile.
Aki von Roy, former EU president of Bristol Myers Squibb and director of Biomatters, acknowledged the achievement of Geneious Pro and said: "To achieve the greater dream of saving enough time to cut two years off the drug development process, will take the widespread adoption of exactly the kind of framework that Geneious Pro offers - a framework that creates the opportunity of making intelligent choices early on".
"Without Geneious," said Batten, "scientists sometimes use as many as four different applications to do sequence alignment and tree-building.
"Because of the constant file imports and cut and paste from these multiple applications, the opportunity for human error is huge".
Geneious 1.0 solved this initial usability problem, with the ability to collect, organise and analyse data from online databases and then perform a range of sequence analyses in one application.
It was quickly adopted by molecular biologists and researchers who responded positively, and was also picked up by universities for teaching.
Next month (July 2006) Geneious 1.0 is expected to extend its user base beyond 10,000.
The more advanced Geneious Pro version now delivers a programme with full collaborative support, manual sequence and alignment editing, more export/import features and ClustalW alignment support.
